Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings

Archives of Internal Medicine

Volumn 166, Issue 14, 2006, Pages 1505-1511

  Cowling, Benjamin J ^a   Muller, Matthew P ^d,e   Wong, Irene O L ^a   Ho, Lai Ming ^a   Lo, Su Vui ^b   Tsang, Thomas ^c   Tai, Hing Lam ^a   Louie, Marie ^e   Leung, Gabriel M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Government of the Hong Kong Special Administrative Region ^*  (Hong Kong)

^c DEPARTMENT OF HEALTH   (Hong Kong)

^d MOUNT SINAI HOSPITAL   (Canada)

^e Canadian SARS Research Network   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HONG KONG; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MORTALITY; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; OXYGEN SATURATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SEVERE ACUTE RESPIRATORY SYNDROME; SEX DIFFERENCE; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; VALIDATION STUDY;

ADULT; AGED; FEMALE; HONG KONG; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; ONTARIO; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERE ACUTE RESPIRATORY SYNDROME; SURVIVAL RATE;

EID: 33746435815     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.14.1505     Document Type: Article

References (48)

1. Zhong NS, Zheng BJ, Li YM, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet. 2003;362:1353-1358.
2. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. http://www.who.int/csr/sars/ country/table2004_04_21/en/index.html. Accessed January 10, 2006.
3. Ghani AC, Donnelly CA, Cox DR, et al. Methods for estimating the case fatality ratio for a novel, emerging infectious disease. Am J Epidemiol. 2005;162:479-486.
4. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276-278.
5. Lau SK, Woo PC, Li KS, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A. 2005;102:14040-14045.
6. Li W, Shi Z, Yu M, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science. 2005;310:676-679.
7. Hak E, Wei F, Nordin J, Mullooly J, Poblete S, Nichol KL. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis. 2004;189:450-458.
8. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005;118:384-392.
9. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-250.
10. Aitchison TC, Sirel JM, Watt DC, MacKie RM; Scottish Melanoma Group. Prognostic trees to aid prognosis in patients with cutaneous malignant melanoma. BMJ. 1995;311:1536-1541.
11. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998;339:1506-1514.
12. Van Houwelingen HC, Thorogood J. Construction, validation and updating of a prognostic model for kidney graft survival. Stat Med. 1995;14:1999-2008.
13. World Health Organisation. Case definitions for surveillance of severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/casedefinition/ en/. Accessed January 10, 2006.
14. Leung GM, Hedley AJ, Ho LM, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med. 2004;141:662-673.
15. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361:1761-1766.
16. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area [published correction appears in JAMA. 2003;290:334]. JAMA. 2003;289:2801-2809.
17. Karlberg J, Chong DS, Lai WY. Domenhave a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol. 2004;159:229-231.
18. Hui DS, Wong KT, Antonio GE, et al. Severe acute respiratory syndrome: correlation between clinical outcome and radiologic features. Radiology. 2004;233:579-585.
19. Chau TN, Lee PO, Choi KW, et al. Value of initial chest radiographs for predicting clinical outcomes in patients with severe acute respiratory syndrome. Am J Med. 2004;117:249-254.
20. Lai EK, Deif H, LaMere EA, et al. Severe acute respiratory syndrome: quantitative assessment from chest radiographs with clinical and prognostic correlation. AJR Am J Roentgenol. 2005;184:255-263.
21. Ko SF, Lee TY, Huang CC, et al. Severe acute respiratory syndrome: prognostic implications of chest radiographic findings in 52 patients. Radiology. 2004;233:173-181.
22. Zou Z, Yang Y, Chen J, et al. Prognostic factors for severe acute respiratory syndrome: a clinical analysis of 165 cases. Clin Infect Dis. 2004;38:483-489.
23. Yang M, Li CK, Li K, et al. Hematological findings in SARS patients and possible mechanisms (review). Int J Mol Med. 2004;14:311-315.
24. Chen CY, Lee CH, Liu CY, Wang JH, Wang LM, Perng RP. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc. 2005;68:4-10.
25. Chan MH, Wong VW, Wong CK, et al. Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome. J Intern Med. 2004;255:512-518.
26. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986-1994.
27. Tsui PT, Kwok ML, Yuen H, Lai ST. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis. 2003;9:1064-1069.
28. Choi KW, Chau TN, Tsang O, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139:715-723.
29. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD. Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making. 2001;21:45-56.
30. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
31. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8:3-15.
32. Harrell FE Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer Verlag; 2001.
33. Little RJA, Rubin DB. Statistical Analysis With Missing Data. 2nd ed. Hoboken, NJ: Wiley; 2002.
34. Altman DG, Bland JM. Diagnostic tests 3: receiver operating characteristic plots. BMJ. 1994;309:188.
35. Efron B. Estimating the error rate of a prediction rule - improvement on cross-validation. J Am Stat Assoc. 1983;78:316-331.
36. World Health Organisation. Use of laboratory methods for SARS diagnosis. http://www.who.int/csr/sars/labmethods/en/. Accessed January 10, 2006.
37. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2005. http://www.R-project.org. Accessed October 2005.
38. Leung GM, Lim WW, Ho LM, et al. Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. Epidemiol Infect. 2006;134:211-221.
39. Leung GM, Chung PH, Tsang T, et al. SARS-CoV antibody prevalence in all Hong Kong patient contacts [published correction appears in Emerg Infect Dis. 2004;10:1890]. Emerg Infect Dis. 2004;10:1653-1656.
40. Leung GM, Rainer TH, Lau FL, et al. A clinical prediction rule for diagnosing severe acute respiratory syndrome in the emergency department. Ann Intern Med. 2004;141:333-342.
41. Cyranoski D. Critics slam treatment for SARS as ineffective and perhaps dangerous. Nature. 2003;423:4.
42. Chan KS, Lai ST, Chu CM, et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J. 2003;9:399-406.
43. Zhaori G. Antiviral treatment of SARS: can we draw any conclusions? CMAJ. 2003;169:1165-1166.
44. Chu CM, Cheng VC, Hung IF, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59:252-256.
45. Chiou HE, Liu CL, Buttrey MJ, et al. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers. Chest. 2005;128:263-272.
46. Chan KH, Poon LL, Cheng VC, et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis. 2004;10:294-299.
47. Poon LL, Chan KH, Wong OK, et al. Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol. 2003;28:233-238.
48. Tang P, Louie M, Richardson SE, et al. Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. CMAJ. 2004;170:47-54.